Homologous Recombination Deficiency as predictive and prognostic genetic marker in ovarian cancer. Bridging the gap between ‘one-size-fits-all’ and a more personalised treatment approach.
Thesis published in 2023 by
Liselore Loverix,
T. Van Gorp 
